AMRN


Stock Update (NASDAQ:AMRN): New In Vitro Eicosapentaenoic Acid Study Data Presented by Amarin Corporation plc (ADR)

Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced the presentation of findings from a new in vitro study at a peer-reviewed poster session at the …

Company Update (NASDAQ:AMRN): Amarin Corporation plc (ADR) Granted Summary Judgment Motion in Suit Against FDA Seeking New Chemical Entity Market Exclusivity for Vascepa® Capsules

Amarin Corporation plc (ADR) (NASDAQ:AMRN), announced today that Judge Randolph D. Moss of the federal district court for the District of Columbia has granted …

Oppenheimer Maintains Cautious Stance On Amarin Following 4Q14 Results

Oppenheimer analyst Akiva Felt came out with his views on Amarin Corporation plc (ADR) (NASDAQ:AMRN), after the company reported its fourth-quarter financial results. The company reported quarterly …

H.C. Wainwright Maintains Neutral On Amarin Following 2Q14 Results

In a research note published August 8th, H.C.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts